Nantahala Capital Management - ANEBULO PHARMACEUTICALS INC ownership

ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 11 filers reported holding ANEBULO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ANEBULO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,561,328
+30.0%
511,0730.0%0.13%
+14.7%
Q2 2023$1,201,022
-19.0%
511,0730.0%0.12%
+1.8%
Q1 2023$1,482,112
+19.7%
511,0730.0%0.11%
+42.5%
Q4 2022$1,238,688
-13.4%
511,0730.0%0.08%
-14.0%
Q3 2022$1,431,000511,0730.09%
Other shareholders
ANEBULO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
22NW, LP 5,066,290$15,477,51611.03%
LVW Advisors, LLC 672,331$2,053,9720.42%
Praetorian PR LLC 177,292$541,6270.28%
Nantahala Capital Management 511,073$1,561,3280.13%
MANGROVE PARTNERS IM, LLC 399,219$1,219,6140.09%
Ikarian Capital, LLC 157,862$503,5800.06%
Tower Research Capital LLC (TRC) 20,851$63,7000.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,978$57,9780.00%
ROYAL BANK OF CANADA 48$00.00%
VANGUARD GROUP INC 22,344$68,2610.00%
View complete list of ANEBULO PHARMACEUTICALS INC shareholders